536 results on '"Dayan, Colin M."'
Search Results
2. A perspective on treating type 1 diabetes mellitus before insulin is needed
3. C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis
4. Maternal type 1 diabetes and relative protection against offspring transmission
5. Cardiovascular morbidity and mortality in patients in Wales, UK with resistance to thyroid hormone β (RTHβ): a linked-record cohort study
6. Controlled Antenatal Thyroid Screening Study III: Effects of gestational thyroid status on adolescent brain morphology
7. Author Correction: A perspective on treating type 1 diabetes mellitus before insulin is needed
8. Evidence for C-peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes
9. Editorial: (Re)defining hypothyroidism: the key to patient-centered treatment
10. Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides
11. Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetes
12. Association of maternal thyroid function with birthweight: a systematic review and individual-participant data meta-analysis
13. C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis
14. Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet antigen-specific CD8+ T cells and exhibit a distinct CD95hi B cell phenotype
15. Pregnancy in teenagers diagnosed with type 1 diabetes mellitus in childhood: a national population-based e-cohort study
16. New insights into the pathogenesis and nonsurgical management of Graves orbitopathy
17. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study
18. Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes
19. Single-cell RNAseq identifies clonally expanded antigen-specific T-cells following intradermal injection of gold nanoparticles loaded with diabetes autoantigen in humans
20. Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial
21. Formulation of hydrophobic peptides for skin delivery via coated microneedles
22. Should radioiodine now be first line treatment for Graves’ disease?
23. Loss of CXCR3 expression on memory B cells in individuals with long-standing type 1 diabetes
24. Global epidemiology of hyperthyroidism and hypothyroidism
25. What does the licensing of teplizumab mean for diabetes care?
26. Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial
27. Single-cell RNAseq identifies clonally expanded antigen-specific T-cells following intradermal injection of gold nanoparticles loaded with diabetes autoantigen in humans
28. Microneedle delivery of autoantigen for immunotherapy in type 1 diabetes
29. Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies
30. Educational Attainment and Childhood-Onset Type 1 Diabetes
31. sj-docx-1-mso-10.1177_20552173221142741 - Supplemental material for Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies
32. The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease).
33. Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189–2201
34. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes
35. Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 Diabetes.
36. Diagnosing Type 1 diabetes in adults:Guidance from the UK T1D Immunotherapy consortium
37. Prescribing costs of hypoglycaemic agents and associations with metabolic control in Wales; a national analysis of primary care data
38. Relationship between thyroid hormones and metabolic syndrome in a normal thyroid function population in Western China
39. Immunotherapy and Prevention of Autoimmune Endocrinopathies
40. Basiliximab Does Not Increase Efficacy of Corticosteroids in Patients With Steroid-Refractory Ulcerative Colitis
41. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta‐analysis
42. General population screening for childhood type 1 diabetes: is it time for a UK strategy?
43. An Invitation to Join the Consortium on Thyroid and Pregnancy
44. Paradoxical Relationship Between Body Mass Index and Thyroid Hormone Levels: A Study Using Mendelian Randomization
45. The beginning of the end for insulin? – enter immunotherapy for T1DM.
46. Insights From Single Cell RNA Sequencing Into the Immunology of Type 1 Diabetes- Cell Phenotypes and Antigen Specificity
47. Replacing insulin with immunotherapy: time for a paradigm change in Type 1 Diabetes
48. The Role of Mitochondria-Linked Fatty-Acid Uptake-Driven Adipogenesis in Graves Orbitopathy
49. Radioiodine and Thyroid Eye Disease
50. Radioiodine and Thyroid Eye Disease: Use with Caution
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.